Nearly 1 in 4 people who have previously had a stroke will experience a recurrent stroke. To help reduce this risk, clinicians will typically recommend antiplatelet or anticoagulant therapy, in ...
Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results